A group based behavioral intervention reduced the sexual risk for HIV infection and transmission by nearly 40% in young transgender women, according to new findings published in JAMA Pediatrics.

Nine countries — Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, the Netherlands and Qatar — are on course to eliminate hepatitis C by 2030, according to data released at the World Hepatitis Summit in São Paulo, Brazil, this week.

Today is a final day of the XVI European AIDS Conference held in Milan (Italy). "European AIDS Conference is a step forward in taking control of HIV/AIDS epidemic in Europe. For us, the representatives of patients in EECA it is important to apply the European principles ...

On September 22, a workshop for patient communities on accessibility of innovation in HIV treatment in Ukraine was held in Kyiv. During the workshop, influential international organizations – the EATG and the East Europe and Central Asia Union of People Living with HIV (ECUO) – ...

AbbVie’s new pangenotypic regimen combining glecaprevir and pibrentasvir cured almost all HIV-positive people with hepatitis C co-infection in the EXPEDITION-2 study, according to a presentation on Monday at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris. Glecaprevir/pibrentasvir (Maviret) is expected to be approved ...

23.07.2017 The results from clinical trials are usually discussed within the scientific community only and are seldom spread to the general public. With the release of the EU Clinical Trials Regulation 536/2014 in 2014, informing the public about clinical trial results will become mandatory in Europe. Lay ...

The Medicines Patent Pool (MPP) released a short film, in which MPP’s stakeholders from industry, government, civil society and patient groups discuss the foundation’s innovative business model, achievements and future plans to increase access to HIV, hepatitis C and TB treatment within the context of ...

UNAIDS’ vision of zero discrimination and ending AIDS by 2030 will only become a reality if the response to HIV reaches everyone, including lesbian, gay, bisexual, transgender and intersex (LGBTI) people. The International Day against Homophobia, Transphobia and Biphobia (IDAHOT), a worldwide celebration of sexual and ...

Recurrent TB and associated factors: A five-year countrywide study in Uzbekistan Abstract Background In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, ...

Treatment Action Group and the ACTION Global Health Advocacy Partnership will host a 2-part webinar series on civil society asks and engagement ahead of the Global Ministerial Conference on TB to be held on 16–17 November 2017 in Moscow, Russian Federation. The two webinars will take ...

Over the next 20 years, cases of drug-resistant tuberculosis (TB) are set to rise in India, the Philippines, Russia, and South Africa – the four countries which already bear the highest burden. A new study published in The Lancet Infectious Diseases says the rise is likely ...

Antiretroviral therapy (ART) has increased life expectancy by a decade in young Europeans and North Americans treated for HIV. Substantial declines in mortality emerged especially for those starting treatment between 2008 and 2010, pointing to the positive effect of evolving therapies and earlier detection. Reporting in ...

DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 26 May 2017. For more information about the webinar and how to connect, click here. Source

The World Health Organization (WHO) updated the fourth edition of the Guidelines for treatment of tuberculosis published in 2010. The Global TB Programme of the World Health Organization convened a meeting of a Guidelines Development Group on 11-13 July 2016 in Geneva, Switzerland in order to ...

The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus (HCV) in adults at low risk in a guideline published in CMAJ (Canadian Medical Association Journal). “Given the lack of direct evidence that mass screening is beneficial and that patients ...

AVAC will host a webinar on the newly released WHO guidance on hormonal contraceptive eligibility for women at high risk of HIV on 26 April 2017. [gview file="http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/04/hc_HIV_guidance_March2017.pdf"] For more information about the webinar and how to register, click here. Sources

Please read and share the letter signed by EATG, as Europe’s transnational HIV treatment and prevention advocacy group, and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs, requesting Gilead Sciences to make it possible for Truvada®, or for generic equivalents of ...

Abstract Background UNAIDS has set a 90-90-90 target to curb the HIV epidemic by 2020, but methods used to assess whether countries have reached this target are not standardised, hindering comparisons. Methods Through a collaboration formed by the European Centre for Disease Prevention and Control (ECDC) with European HIV ...